froggmister
4 minutes ago
First, the FDA did not say outright no to the first of the two phase 2 trials Dendreon tried to push across the line. The ADCOM, including Pazdur, said yes, 13 to 4, but the FDA, seeing that they had another phase 2 that was going read out in a year, decided to wait for those results- much to the ch